A novel study evaluated the use of dermoscopy and clinical evaluation in monitoring biologic treatment of atopic dermatitis.
Cancer incidence in children with atopic dermatitis treated with topical tacrolimus was as expected in a study examining their possible relationship.
The high prevalence of mental health issues seen in adolescents with atopic dermatitis suggests that successful management of the disease involve a multidisciplinary approach.
Treatment guidelines are provided and vigilance recommended by the European Task Force on Atopic Dermatitis.
Children who were exposed to phthalates either prenatally or during early life did not necessarily incur a higher risk for allergic diseases.
Predictors of longer and shorter postdrug survival in children with atopic dermatitis who started a second-line therapy have been found.
There appears to be much racial and ethnic disparity in global atopic dermatitis clinical trials despite the disease’s prevalence in developed nations.
confirmed structural validity has been developed to assess quality of life in children with atopic dermatitis.
Adverse childhood experience, particularly the occurrence of multiple experiences including physical or emotional abuse, are associated with increased chance of atopic dermatitis.
Patients with a positive family history of atopy had an almost 3-fold greater risk for developing atopic dermatitis, regardless of common FLG mutation status.